- Fee assured
- Verified account
- Lower GI
- Home chemotherapy
I trained in London as a house doctor and senior house officer, Oxford as a registrar and research fellow, Newcastle as a senior registrar and
I was awarded the Cancer Research Campaign Travelling Fellowship in 1981 to train as a Clinical Fellow at the Dana Farber Cancer Institute in Boston before returning to the UK to take up a senior lectureship and hon consultant post in Edinburgh where I worked for 19 years helping to start the academic medical oncology department.
I was offered the new Chair of Medical Oncology and Chair of the South West Wales Cancer Institute in 2001 and left 5 years later to lead the oncology department at Imperial College NHS Trust as a Professor of Oncology. I retired from the NHS in 2011.
Areas of interest
Breast cancer colorectal cancer;lymphoma
Investigation, management, treatment with drug therapy
Molecular profiling of cancer for therapy targeting
Current NHS consultant posts held
I no longer work as an NHS consultant but I continue to consult at the private wings of both Charing Cross and Hammersmith Hospitals.
Published over 300 papers on the biology and treatment of human cancer for over 40 years.
In recent focus has been on the management of breast cancer currently on the the value of molecular profiling of advanced cancer to better select effective drug therapy.
Set up the Anglo Celtic Collaborative Oncology Group- trials in breast cancer continue.
Help set up Maggies Cancer Caring Charity with my patient, Maggie Jencks and research nurse , Laura Lee who is now Chief Executive
Now over 15 centres at major Cancer Centre sites in UK and abroad
Main Board Medical Member and Chair Professional Advisory Board
Ex-Chair Research Committee 'Breast Cancer Care'
Continue sporting activity in football, golf.
Amateur astronomy, cosmology
Medical School Final Year Prizes in Medicine, surgery, pathology and clinical medal.
Postgraduate research prize in Oxford
Cancer Research Campaign Traveliing Fellow to Dana Farber Cancer Centre, Boston 1981-2
Team leader and Finalist in Hospital Doctor of the Year Oncology 1994
Finalist Communication in Oncology 1995
2005 Special Commendation Hospital Doctor of the Year-Oncology Team
(Additional) Languages spoken
- French - Conversational
- Spanish - Basic
A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor ('SPROG' trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN.
Leonard RC, et al Anglo-Celtic Collaborative Oncology Group. Ann Oncol. 2015 Sep 28.
Berry DA, Ueno NT, Johnson MM, Lei X, Caputo J, Rodenhuis S, Peters WP,
Leonard RC, Barlow WE, Tallman MS, Bergh J, Nitz UA, Gianni AM, Basser RL, Zander
AR, Coombes RC, Roch√© H, Tokuda Y, de Vries EG, Hortobagyi GN, Crown JP,
Pedrazzoli P, Bregni M, Demirer T. High-dose chemotherapy with autologous
stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized
trials. J Clin Oncol. 2011 Aug 20;29(24):3214-23
Mansi JL, Yellowlees A, Lipscombe J, Earl HM, Cameron DA, Coleman RE, Perren T,
Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Evans TR.
Five-year outcome for women randomised in a phase III trial comparing doxorubicin
and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in
early breast cancer: an Anglo-Celtic Cooperative Oncology Group study. Breast Cancer Res Treat. 2010 Aug;122(3):787-94.
Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J, Leonard RC; Anglo Celtic Co-operative Oncology Group. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer. 2006 Dec 18;95(12):1626-31
Poole CJ, Earl HM, Hiller L, Dunn JA, Bathers S, Grieve RJ, Spooner DA, Agrawal RK, Fernando IN, Brunt AM, O'Reilly SM, Crawford SM, Rea DW, Simmonds P, Mansi JL, Stanley A, Harvey P, McAdam K, Foster L, Leonard RC, Twelves CJ; NEAT Investigators and the SCTBG. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. N Engl J Med. 2006 Nov 2;355(18):1851-62.
Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann
Courses offered to GPs
Many seminars in UK and internationally on breast cancer; importance of dose intensity for adjuvant chemotherapy
Recently- molecular profiling for advanced cancer management
Strong supportive comments from patients on my GMC revalidation submission in 2014
- BSc MB BS London University 1971
- MRCP Royal College of Physicians 1974
- MD London University 1980
- Clinical Fellowship in Medical Oncology Harvard University 1981
Reference number 1488155
Professional bodies (positions held - last 3 yrs)
- Fellow of the Royal Colleges of Physicians England and Edinburgh 1993
Details of entry to specialist register
- Medicine, Medical Oncology, 1982
Affiliations / memberships
American Society of Clinical Oncology
Association of Cancer Physicians
Scottish Radiological Society
British Breast Group
Society Oncologie Geriatrique
- 15th Floor, Private Patients DepartmentFulham...
- 12:30 - 17:00
- 07980 242225
- BUPA Cromwell Hospital
- 12:00 - 17:00
- 07980 242225
- Bupa Cromwell Hospital164-178 Cromwell...
- 12:30 - 17:30
- 07980 242225
- London Clinic, W1G 6BW
- 12:00 - 15:00
- 07980 242225
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details